Navidea Biopharma (NYSE: NAVB) announced that the Tel Aviv Stock Exchange (TASE) has approved the new listing of Navidea's common ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE